SHENYANG, China, Sept. 17 /Xinhua-PRNewswire/ -- 3SBio Inc. (Nasdaq: SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, announced that David Chen, Chief Operating Officer, will present at the UBS Global Life Sciences Conference in New York on Thursday, September 25, 2008 at 10:30AM (Eastern Time).
The presentation will be webcast live (audio only) and can be accessed on the Conference Appearances section of the Investors page of the 3SBio website at: http://bbs.3sbio.com/en/News/ShowInfo_nnn6.aspx?ID=65 . A replay of the presentation and accompanying slides will be available on the 3SBio website until October 25, 2008.
About 3SBio Inc.
3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China.
For more information, please visit 3SBio on the web at: http://www.3sbio.com .
